David Diller
15Patents
6h-index
40Co-inventors
66Inventor score
Filing activity: Jun 15, 2000 → Oct 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7902187B2 | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression | Chemistry; Metallurgy | 20 | Active |
| US7919490B2 | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression | Chemistry; Metallurgy | 18 | Active |
| US7065453B1 | Molecular docking technique for screening of combinatorial libraries | Physics | 15 | Expired |
| US7253174B2 | N-heterocyclic inhibitors of TNF-α expression | Chemistry; Metallurgy | 12 | Active |
| US7951803B2 | 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders | Human Necessities | 8 | Active |
| US8044040B2 | N-heterocyclic inhibitors of TNF-alpha expression | Chemistry; Metallurgy | 6 | Active |
| US10030034B2 | Heterocycle amines and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7989459B2 | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors | Human Necessities | 4 | Active |
| US9266874B2 | Heterocycle amines and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US11186593B2 | Heterocycle amines and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10604533B2 | Heterocycle amines and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11161864B2 | Sting agonists | Human Necessities | 0 | Active |
| US11773110B2 | Heterocycle amines and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11110106B2 | Sting agonists for treating bladder cancer and solid tumors | Human Necessities | 0 | Active |
| US11883420B2 | Sting agonists for treating bladder cancer and solid tumors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.